76. Herrmann I, Li ZA, Bahal R, Conde J. “Translating nanomedicines from the lab to the clinic”, Cell Reports Physical Sciences, 2025.

75. Ruchi R, Raman G, Kumar V*, Bahal R.* “Evolution of Antisense Oligonucleotides: Navigating Nucleic Acid Chemistry and Delivery Challenges”, Expert Opinion on Drug Discovery, 2024 (Accepted). *(corresponding authors)

74. Laddha AP, Wahane A, Bahal R, Manautou J.* “Investigating the Crosstalk Between ABCC4 and ABCC5 in 3T3-L1 Adipocyte Differentiation“ , Frontiers in Molecular Biosciences, 2024 (Accepted). *(corresponding author)

73. Pradeep SP, Bahal R. “Advancements in cell-penetrating monoclonal antibody treatment.” Oncotarget, 2024 (Accepted).

72. Kumar V, Wahane A, Tham MS, Somlo S, Gupta A, Bahal R. “Efficient and selective kidney targeting by chemically modified carbohydrate conjugates” Molecular Therapy, 2024.

71. De A, Bahal R. “Double-stranded DNA invasion by anti-gene oligonucleotide clamps” Molecular Therapy Nucleic Acids, 2024 (Accepted).

70. Wahane A^#, Kasina V^#, Pathuri M, Marro-Wilson C, Gupta A, Slack F, Bahal R. “Development of bioconjugate-based delivery systems for nucleic acids.” RNA, 2024 (Accepted). # authors contributed equally

69. Yadav SK, Dhuri K, Turro DG, Cormier MK, Patel V, Yadawa AK, Pathuri M, Bahal R*, Verma R*. “Exploring the Therapeutic Potential of sγPNA-1 141: Pharmacodynamics and Mechanistic insights during Ischemic Stroke Recovery” Molecular Therapy Nucleic Acids, 2024 (Accepted). *co-corresponding senior authors

68. Pradeep SP, Kumar V, Malik S, Slack FJ, Gupta A, Bahal R. “Enhancing RNA inhibitory activity using clamp-G modified nucleobases.” Cell Reports Physical Sciences, 2024.

67. Sang A^#, Zhuo S^#, Bochanis A^#, Manautou J, Bahal R, Zhong X, and Rasmussen T. “Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs.” Biodrugs, 2024 (Accepted). ^#authors contributed equally.

66. Malik S^#, Pradeep SP^#, Kumar V, Xiao Y, Deng Y, Fan R, Vasquez JC, Singh V, Bahal R. “Antitumor efficacy of sequence-specific DNA-targeted gamma PNA-based c-Myc inhibitor” . Cell Reports Medicine, 2024. ^#authors contributed equally.

65. Gogate A, Belcourt J, Shah M, Wang A, Frankel A, Kolmel H, Chalon M, Stephen P, Kolli A, Tawfik S, Jin J, Bahal R, Rasmussen T, Manautou J, and Zhong X. “Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin.” Pharmacological Reviews, 2024.

64. Oyaghire SN, Quijano E, Perera JDR, Mandl HK, Saltzman WM, Bahal R, Glazer PM. “DNA Recognition and Induced Genome Modification by a Hydroxymethyl-γ Tail-Clamp Peptide Nucleic Acid” . Cell Reports Physical Sciences, 2023.

63. Dhuri K, Duran T, Chaudhuri B, Slack FJ, Vikram A, Glazer PM, Bahal R. “Head to Head comparison of in vitro and in vivo efficacy of pHLIP conjugated anti seed gamma Peptide Nucleic Acids“. Cell Reports Physical Sciences, 2023.

62. Gaddam RR, Amalkar V, Sali VK, Nakuluri K, Jacobs JS, Kim YR, Li Q, Bahal R, Irani K, Vikram A. “Role of miR-204 in segmental cardiac effects of phenylephrine and pressure overload“. Biochemical and Biophysical Research Communications, 2023.

61. Kasina V, Wahane A, Liu CH, Yang L, Nieh MP, Slack FJ, Bahal R. “Next-generation poly-L-histidine formulations for miRNA mimic delivery“. Molecular Therapy Methods & Clinical Development, 2023.

60. Pradeep SP, Malik S, Slack FJ*, Bahal R*. “Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics“. RNA, 2023. *Co-corresponding authors.

59. Kumar V, Wahane A, Gupta A, Manautou JE, Bahal R. “Multivalent Lactobionic acid and N-Acetylgalactosamine-conjugated Peptide Nucleic Acids for Efficient in vivo Targeting of Hepatocytes“. Advanced Healthcare Materials, 2023.

58. Wang Y#, Malik S#, Suh HW, Xiao Y, Deng Y, Fan R, Huttner A, Bindra RS, Singh V, Saltzman WM*, Bahal R*. “Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy“. Science Advances, 2022. #Both authors contributed equally, *co-corresponding senior authors.

57. Ahangari F, Price NL, Malik S, Chioccioli M, Bärnthaler T, Adams TS, Kim J, Pradeep SP, Ding S, Cosme Jr C, Rose K, McDonough J, Aurelien N, Ibarra G, Omote N, Schupp JC, DeIuliis G, Villalba JA, Sharma L, Ryu C, Dela Cruz C, Liu X, Prasse A, Rosas I, Bahal R, Fernandez-Hernando C, Kaminski N. “microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis“. JCI Insight, 2023.